A 64-year-old man who developed persistent hemoptysis for 2 months. Chest CT scan with contrast enhancement showed an irregular lesion, about 4.0 x 1.5 x 1.2 cm in size over right lower lobe with pleural thickening, mediastinal lymphadenopathy, adrenal gland and bone me-tastasis. The pathology of bronchoscopic tissue biopsy showed small cell lung cancer. During hospitalization, he complained of epigastralgia with radiation to the back. The blood test showed elevated amylase and lipase levels. The magnetic resonance imaging (MRI) revealed swollen pancreas but no choledocholithiasis. Acute pancreatitis was diagnosed. Pancreatitis re-lapsed again after conservative treatment. After reviewing the previous imaging study, a low-density lesion in ...
This is an open-access article distributed under the terms of the Creative Commons Attribution Licen...
International audienceRationale: Despite clinical-proven benefits of immune checkpoint inhibitors (I...
Background: Pancreatic lymphoma is uncommon, representing less than 0.5\% of pancreatic tumors, with...
Although involvement of pancreas is a common finding in small cell lung cancer (SCLC), metastasis-in...
Lung cancer metastases can occur in almost any organ. However, metastasis of small cell lung cancer ...
Context Pancreatic metastases are relatively common in advanced lung cancers (both small cell lung c...
In lung cancer, metastasis to the liver, bones, brain, and adrenal glands is more commonly observed,...
A case of metastasis-induced acute pancreatitis in a patient with small cell lung cance
In the diagnosis and treatment of non-small cell lung cancer (NSCLC), the histological type may chan...
This report aims to highlight the importance of malignancy exclusion in the absence of common aetiol...
Small-cell lung carcinoma represents a group of highly malignant tumors characterized by early and w...
Drug-induced acute pancreatitis (DIP) is a recognised but underreported entity in the literature. Im...
Unlike primary pancreatic carcinoma, metastatic lesions of the pancreas are uncommon and account for...
Background: Small-cell lung cancer (SCLC) is known to express antigens of both the neural crest and ...
Introduction:Little information is available concerning the prognosis and treatment of metastasis-in...
This is an open-access article distributed under the terms of the Creative Commons Attribution Licen...
International audienceRationale: Despite clinical-proven benefits of immune checkpoint inhibitors (I...
Background: Pancreatic lymphoma is uncommon, representing less than 0.5\% of pancreatic tumors, with...
Although involvement of pancreas is a common finding in small cell lung cancer (SCLC), metastasis-in...
Lung cancer metastases can occur in almost any organ. However, metastasis of small cell lung cancer ...
Context Pancreatic metastases are relatively common in advanced lung cancers (both small cell lung c...
In lung cancer, metastasis to the liver, bones, brain, and adrenal glands is more commonly observed,...
A case of metastasis-induced acute pancreatitis in a patient with small cell lung cance
In the diagnosis and treatment of non-small cell lung cancer (NSCLC), the histological type may chan...
This report aims to highlight the importance of malignancy exclusion in the absence of common aetiol...
Small-cell lung carcinoma represents a group of highly malignant tumors characterized by early and w...
Drug-induced acute pancreatitis (DIP) is a recognised but underreported entity in the literature. Im...
Unlike primary pancreatic carcinoma, metastatic lesions of the pancreas are uncommon and account for...
Background: Small-cell lung cancer (SCLC) is known to express antigens of both the neural crest and ...
Introduction:Little information is available concerning the prognosis and treatment of metastasis-in...
This is an open-access article distributed under the terms of the Creative Commons Attribution Licen...
International audienceRationale: Despite clinical-proven benefits of immune checkpoint inhibitors (I...
Background: Pancreatic lymphoma is uncommon, representing less than 0.5\% of pancreatic tumors, with...